308 related articles for article (PubMed ID: 12142171)
1. Nucleoside analogues and nucleobases in cancer treatment.
Galmarini CM; Mackey JR; Dumontet C
Lancet Oncol; 2002 Jul; 3(7):415-24. PubMed ID: 12142171
[TBL] [Abstract][Full Text] [Related]
2. Pyrimidine nucleoside analogs in cancer treatment.
Galmarini CM; Jordheim L; Dumontet C
Expert Rev Anticancer Ther; 2003 Oct; 3(5):717-28. PubMed ID: 14599094
[TBL] [Abstract][Full Text] [Related]
3. New nucleoside analogs in the treatment of hematological disorders.
Szafraniec SI; Stachnik KJ; Skierski JS
Acta Pol Pharm; 2004; 61(3):223-32. PubMed ID: 15481249
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
Galmarini CM; Popowycz F; Joseph B
Curr Med Chem; 2008; 15(11):1072-82. PubMed ID: 18473803
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer evaluation of 4'-C-methyl-2'-fluoro arabino nucleosides.
Tiwari KN; Shortnacy-Fowler AT; Parker WB; Waud WR; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):657-77. PubMed ID: 20183608
[TBL] [Abstract][Full Text] [Related]
6. Purine analogs and related nucleosides and nucleotides as antitumor agents.
Robins RK; Revankar GR
Med Res Rev; 1985; 5(3):273-96. PubMed ID: 3894832
[No Abstract] [Full Text] [Related]
7. Purine and pyrimidine nucleoside analogs.
Plunkett W; Gandhi V
Cancer Chemother Biol Response Modif; 2001; 19():21-45. PubMed ID: 11686015
[No Abstract] [Full Text] [Related]
8. Basis for clinical resistance to antitumor nucleoside analogs.
Hall TC
Ann N Y Acad Sci; 1975 Aug; 255():235-43. PubMed ID: 1103683
[No Abstract] [Full Text] [Related]
9. Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues.
Degrève B; De Clercq E; Balzarini J
Gene Ther; 1999 Feb; 6(2):162-70. PubMed ID: 10435100
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside analogs in the treatment of neoplastic and nonneoplastic diseases.
Slavik M
Ann N Y Acad Sci; 1975 Aug; 255():266-8. PubMed ID: 1059360
[No Abstract] [Full Text] [Related]
11. Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2006 May; 6(5):575-81. PubMed ID: 16719832
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of astrocyte proliferation by purine and pyrimidine nucleotides and nucleosides.
Christjanson LJ; Middlemiss PJ; Rathbone MP
Glia; 1993 Feb; 7(2):176-82. PubMed ID: 8432558
[TBL] [Abstract][Full Text] [Related]
13. Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5'-Monophosphate Forms of Anticancer Nucleoside Analogues.
Slusarczyk M; Ferrari V; Serpi M; Gönczy B; Balzarini J; McGuigan C
ChemMedChem; 2018 Nov; 13(21):2305-2316. PubMed ID: 30199147
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of N-sulfonyl derivatives of nucleobases and sulfonamido nucleoside derivatives.
Zinić B; Krizmanić I; Glavas-Obrovac Lj; Karner I; Zinić M
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1623-5. PubMed ID: 14565481
[TBL] [Abstract][Full Text] [Related]
15. Nucleobase and nucleoside transport in mammalian cells.
Kraupp M; Marz R
Wien Klin Wochenschr; 1995; 107(22):677-80. PubMed ID: 8533427
[TBL] [Abstract][Full Text] [Related]
16. Recent developments to improve the efficacy of cytotoxic nucleoside analogues.
Jordheim LP; Galmarini CM; Dumontet C
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):163-70. PubMed ID: 18221034
[TBL] [Abstract][Full Text] [Related]
17. Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation.
Hatse S; De Clercq E; Balzarini J
Biochem Pharmacol; 1999 Aug; 58(4):539-55. PubMed ID: 10413291
[TBL] [Abstract][Full Text] [Related]
18. Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents.
Von Hoff DD; Rozencweig M; Soper WT; Helman LJ; Penta JS; Davis HL; Muggia FM
Cancer Treat Rep; 1977 Aug; 61(5):759-68. PubMed ID: 890691
[TBL] [Abstract][Full Text] [Related]
19. Purine nucleoside antimetabolites in development for the treatment of cancer.
Parker WB; Secrist JA; Waud WR
Curr Opin Investig Drugs; 2004 Jun; 5(6):592-6. PubMed ID: 15242246
[TBL] [Abstract][Full Text] [Related]
20. Mouse equilibrative nucleoside transporter 2 (mENT2) transports nucleosides and purine nucleobases differing from human and rat ENT2.
Nagai K; Nagasawa K; Kyotani Y; Hifumi N; Fujimoto S
Biol Pharm Bull; 2007 May; 30(5):979-81. PubMed ID: 17473446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
